Brief: Aerovate Therapeutics posts Q1 basic EPS USD -0.67
15/05/2023 21:07
May 15 (Reuters) - Aerovate Therapeutics Q1 basic EPS USD -0.67. * Q1 cash & investments USD 118.9 million * Q1 net income USD -16.5 million
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million